BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 22922418)

  • 1. Orphan kidney diseases.
    Soliman NA
    Nephron Clin Pract; 2012; 120(4):c194-9. PubMed ID: 22922418
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rare inherited disorders with renal involvement-approach to the patient.
    Joly D; Béroud C; Grünfeld JP
    Kidney Int; 2015 May; 87(5):901-8. PubMed ID: 25651365
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Current views on rare diseases research and orphan drugs development].
    Jiang J; Li J; Liu W
    Sheng Wu Gong Cheng Xue Bao; 2011 May; 27(5):724-9. PubMed ID: 21845839
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Understanding rare renal conditions.
    Wise S
    Nurs Times; 2013 Dec 23-2014 Jan 14; 109(51):14-5. PubMed ID: 24592658
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rare inherited kidney diseases: challenges, opportunities, and perspectives.
    Devuyst O; Knoers NV; Remuzzi G; Schaefer F;
    Lancet; 2014 May; 383(9931):1844-59. PubMed ID: 24856029
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Recent developments in genetic kidney diseases].
    Liebau MC; Benzing T
    Dtsch Med Wochenschr; 2011 May; 136(19):1014-20. PubMed ID: 21544793
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Providing guidance in the dark: rare renal diseases and the challenge to improve the quality of evidence.
    Bolignano D; Nagler EV; Van Biesen W; Zoccali C
    Nephrol Dial Transplant; 2014 Sep; 29(9):1628-32. PubMed ID: 24026240
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Towards efficiency in rare disease research: what is distinctive and important?
    Jia J; Shi T
    Sci China Life Sci; 2017 Jul; 60(7):686-691. PubMed ID: 28639105
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monogenic renal diseases: a clinical introduction.
    Grünfeld JP
    J Nephrol; 2002; 15 Suppl 6():S43-6. PubMed ID: 12515373
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Genetic mutation databases: stakes and perspectives for orphan genetic diseases].
    Humbertclaude V; Tuffery-Giraud S; Bareil C; Thèze C; Paulet D; Desmet FO; Hamroun D; Baux D; Girardet A; Collod-Béroud G; Khau Van Kien P; Roux AF; des Georges M; Béroud C; Claustres M
    Pathol Biol (Paris); 2010 Oct; 58(5):387-95. PubMed ID: 19954899
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rare neurological diseases: a Pandora's box for neurology (an European and Italian perspective).
    Federico A
    Rev Neurol (Paris); 2013 Feb; 169 Suppl 1():S12-7. PubMed ID: 23452765
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Orphanet and its consortium: where to find expert-validated information on rare diseases].
    Maiella S; Rath A; Angin C; Mousson F; Kremp O
    Rev Neurol (Paris); 2013 Feb; 169 Suppl 1():S3-8. PubMed ID: 23452769
    [TBL] [Abstract][Full Text] [Related]  

  • 13. How did uncommon disorders become 'rare diseases'? History of a boundary object.
    Huyard C
    Sociol Health Illn; 2009 May; 31(4):463-77. PubMed ID: 19397760
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current management of transition of young people affected by rare renal conditions in the ERKNet.
    Kreuzer M; Drube J; Prüfe J; Schaefer F; Pape L;
    Eur J Hum Genet; 2019 Dec; 27(12):1783-1790. PubMed ID: 31363187
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hereditary kidney diseases: highlighting the importance of classical Mendelian phenotypes.
    Benoit G; Machuca E; Heidet L; Antignac C
    Ann N Y Acad Sci; 2010 Dec; 1214():83-98. PubMed ID: 20969579
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Good-quality research in rare diseases: trials and tribulations.
    Bolignano D; Pisano A
    Pediatr Nephrol; 2016 Nov; 31(11):2017-23. PubMed ID: 26817476
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemical genetics and orphan genetic diseases.
    Lunn MR; Stockwell BR
    Chem Biol; 2005 Oct; 12(10):1063-73. PubMed ID: 16242649
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Orphan drug legislation: lessons for neglected tropical diseases.
    Villa S; Compagni A; Reich MR
    Int J Health Plann Manage; 2009; 24(1):27-42. PubMed ID: 18435430
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug development for orphan diseases in the context of personalized medicine.
    Brewer GJ
    Transl Res; 2009 Dec; 154(6):314-22. PubMed ID: 19931198
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug repositioning for orphan diseases.
    Sardana D; Zhu C; Zhang M; Gudivada RC; Yang L; Jegga AG
    Brief Bioinform; 2011 Jul; 12(4):346-56. PubMed ID: 21504985
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.